Pediatric idiopathic intracranial hypertension: A review

Pediatrics in Review

Volumn 28, Issue 11, 2007, Pages

  Mercille, Genevieve ^a   Ospina, Luis H ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMIODARONE; CORTICOSTEROID; DANAZOL; FUROSEMIDE; HUMAN GROWTH HORMONE; LITHIUM; MESALAZINE; MINOCYCLINE; NALIDIXIC ACID; NITROFURANTOIN; ORAL CONTRACEPTIVE AGENT; RETINOL DERIVATIVE; STEROID; TETRACYCLINE; THYROID HORMONE;

ANOREXIA; CHILDHOOD DISEASE; CLINICAL FEATURE; DEHYDRATION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOKALEMIA; HYPOTENSION; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; KIDNEY CALCIFICATION; METABOLIC ACIDOSIS; PATHOGENESIS; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN TINGLING; SYMPTOMATOLOGY; TASTE DISORDER; TREATMENT INDICATION; TREATMENT OUTCOME; WEIGHT GAIN;

ADOLESCENT; ADULT; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEADACHE; HUMANS; INTRACRANIAL HYPERTENSION; MALE; OBESITY; PAPILLEDEMA; PHYSICAL EXAMINATION; RISK FACTORS;

EID: 36048943428     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.28-11-e77     Document Type: Review

References (103)

1. Quincke H. Uber meningitis serosa and verewandte zustande. Deutsche Zeitschrift fur Nervenheilkunde. 1897;9:149-168
2. Wall M. Idiopathic intracranial hypertension. Neurol Clin. 1991;9:73-95
3. Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492-1495
4. Radhakrishnan K, Ahlskog JE, Garrity JA, et al. Idiopathic intracranial hypertension. Mayo Clin Proc. 1994;69:169-180
5. Friedman DI. Pseudotumor cerebri. Neurol Clin North Am. 2004;22:99-131
6. Kesler A, Fattal-Valveski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol. 2002;17:745-748
7. Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci. 1997;24:219-221
8. Cinciripini GS, Donahue S, Borchet MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, outcome. Am J Ophthalmol. 1999;127:178-182
9. Babikian P, Corbett J, Bell W. Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol. 1994;8:144-149
10. Lessell S. Pediatric pseudotumor cerebri (idiopathic intracranial hypertension). Surv Ophthalmol. 1992;37:155-166
11. Distelmaier F, Sengler U, Messing-Juenger M, Assmann B, Mayatepek E, Rosenbaum T. Pseudotumor cerebri as an important differential diagnosis of papilledema in children. Brain Dev. 2006;28:190-195
12. Phillips PH, Repka MX, Lambert SR. Pseudotumor cerebri in children. J AAPOS. 1998;2:33-38
13. Balcer LJ, Liu GT, Forman S. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology. 1999;52:870-872
14. Kharode C, McAbee G, Sherman J, Kaufman F. Familial intracranial hypertension: report of a case and review of literature. J Child Neurol. 1992;7:196-198
15. Soler D, Cox T, Bullock P, Calver DM, Robinson RO. Diagnosis and management of benign intracranial hypertension. Arch Dis Child. 1998;78:89-94
16. Kesler A, Bassan H. Pseudotumor cerebri-idiopathic intracranial hypertension in the pediatric population. Pediatr Endocrinol Rev. 2006;4:387-392
17. Troost BT, Sufit RL, Grand MG. Sudden monocular visual loss in pseudotumor cerebri. Arch Ophthalmol. 1979;36:440-442
18. Green GJ, Lessell S, Lowenstein JL. Ischemic optic neuropathy in chronic papilledema. Arch Ophthalmol. 1980;98:502-504
19. Shin RK, Balcer LJ. Idiopathic intracranial hypertension. Curr Treat Opt Neurol. 2002;4:297-305
20. Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29-37
21. Quinn AG, Singer SB, Buncic JR. Pediatric tetracycline-induced pseudotumor cerebri. J AAPOS. 1999;3:53-57
22. Rogers AH, Rogers GL, Bremer DL, McGregor ML. Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology. 1999;106:1186-1190
23. Riyaz A, Aboobacker CM, Sreelatha PR. Nalidixic acid induced pseudotumor cerbri in children. J Indian Med Assoc. 1998;96:313-314
24. Rottembourg D, Labarthe F, Arsene S, Jonville-Béra AP, Maurage C, Rolland JC. Headache during mesalamine therapy: a case report of mesalamine-induced pseudotumor cerebri. J Pediatr Gastroenterol. 2001;33:337-338
25. Raghavan S, DiMartino-Nardi J, Saenger P, Linder B. Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism. J Pediatr. 1997;130:478-480
26. Glueck CJ, Aregawi D, Goldenberg N, Golnik K, Sieve L, Wang P. Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. J Lab Clin Med. 2005;145:72-82
27. Condulis N, Germain G, Charest N, Levy S, Carpenter TO. Pseudotumor cerebri: a presenting manifestation of Addison's disease. Clin Pediatr. 1997;36:711-714
28. Tamer SK, Tamer U, Warey P. Infantile pseudotumor cerebri related to viral illness. Indian J Pediatr. 1996;63:645-649
29. Keren T, Lahat E. Pseudotumor cerebri as a presenting symptom of acute sinusitis in a child. Pediatr Neurol. 1998;19:153-154
30. Steenhoff AP, Smith MJ, Shah SS, Coffin SE. Neuroborreliosis with progression from pseudotumor cerebri to aseptic meningitis. Pediatr Infect Dis. 2006;25:91-92
31. Konrad D, Kuster H, Hunziker UA. Pseudotumor cerebri after varicella. Eur J Pediatr. 1998;157:904-906
32. Francis PJ, Haywood S, Ridgen S, Calver D, Clark G. Benign intracranial hypertension in children following renal transplantation. Pediatr Nephrol. 2003;18:1265-1269
33. Mewasingh LD, Sékhara T, Dachy B, Djeunang MC, Dan B. Benign intracranial hypertension: atypical presentation of Miller Fisher syndrome? Pediatr Neurol. 2002;26:228-230
34. Chaves-Carballo E, Dabbagh O, Bahabri S. Pseudotumor cerebri and leukoencephalopathy in childhood lupus. Lupus. 1999;8:81-84
35. Koné-Paut I, Chabrol B, Riss JM, Mancini J, Raybaud C, Garnier JM. Neurologic onset of Behçet's disease: a diagnostic enigma in childhood. J Child Neurol. 1997;12:237-241
36. Margalit E, Do DV, Tohay K, Nguyen QD. Panuveitis in association with pseudotumor cerebri. J Child Neurol. 2005;20:234-236
37. Henry M, Driscoll MC, Miller M, Chang T, Minniti CP. Pseudotumor cerebri in children with sickle cell disease: a case series. Pediatrics. 2004;113:265-269
38. Glueck CJ, Goldenberg N, Golnik K, Sieve L, Wang P. Idiopathic intracranial hypertension: associations with thrombophilia and hypofibrinolysis in men. Clin Appl Thrombosis Hemostasis. 2005;11:441-448
39. Dunkley S, Johnston I. Thrombophilia as a common predisposing factor in pseudotumor cerebri. Blood. 2004;103:1972-1973
40. Scott IU, Siatkowski RM, Eneyni M, Brodsky MC, Lam BL. Idiopathic intracranial hypertension in children and adolescents. Am J Ophthalmol. 1997;124:253-254
41. Couch R, Camfield PR, Tibbles JAR. The changing picture of pseudotumor cerebri in children. Can J Neurol Sci. 1985;12:48-50
42. Grant DN. Benign intracranial hypertension: a review of 79 cases in infancy and childhood. Arch Dis Child. 1971;46:651-655
43. Baker RS, Carter D, Hendrick EB, Buncik JR. Visual loss in pseudotumor cerebri in childhood: a follow-up study. Arch Ophthalmol. 1985;103:1681-1686
44. Brodsky M, Baker RS, Hamed LM. The swollen optic disc in childhood. In: Pediatric Neuro-ophthalmology. New York, NY: Springer-Verlag; 1996:80-87
45. Jones JS, Nevai J, Freeman MP, McNinch DE. Emergency department presentation of idiopathic intracranial hypertension. Am J Emerg Med. 1999;17:517-521
46. Auw-Haedrich C, Staubach F, Witschel H. Optic disk drusen. Surv Ophthalmol. 2002;47:15-32
47. Lorentzen SE. Drusen of the optic disc. Dan Med Bull. 1967;14:293-298
48. Baker RS, Baumann RJ, Buncic JR. Idiopathic intracranial hypertension (pseudotumor cerebri) in pediatric patients. Pediatr Neurol. 1989;5:5-11
49. Capobianco DJ, Brazis PW, Cheshire WP. Idiopathic intracranial hypertension and seventh nerve palsy. Headache. 1997;37:286-288
50. Straussberg R, Harel L, Amir J. Pseudotumor cerebri presenting as stiff neck and torticollis. Pediatr Neurol. 2002;26:225-227
51. Weig SG. Asymptomatic idiopathic intracranial hypertension in young children. J Child Neurol. 2002;17:239-241
52. Friedman DI. Papilledema. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's Clinical Neurophthalmology. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005:237-291
53. Orcutt JC, Page NGR, Sanders MD. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology. 1984;91:1303-1312
54. Sergott RC, Savino PJ, Bosley TM. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol. 1988;106:1384-1390
55. Rossiter JD, Lockwood AJ, Evans AR. Coexistence of optic disc drusen and idiopathic intracranial hypertension in a child. Eye. 2005;19:234-235
56. Hoyt WK, Beeston D. The Ocular Fundus in Neurologic Disease. St Louis, Mo: CV Mosby; 1966
57. Walsh TJ, Garden JW, Gallaher B. Obliteration of retinal venous pulsations. Am J Ophthalmol. 1969;67:954-956
58. Speer C, Pearlman J, Phillips PH, Cooney M, Repka MX. Fourth cranial nerve palsy in pediatric patients with pseudotumor cerebri. Am J Ophthalmol. 1999;127:236-237
59. Farb RI, Vaneck I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology. Neurology. 2003;60:1418-1424
60. Said RR, Rosman NP. A negative cranial computed tomographic scan is not adequate to support the diagnosis of pseudotumor cerebri. J Child Neurol. 2004;19:609-613
61. Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology. 1999;53:1537
62. Brodsky MC, Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmol. 1998;105:1686-1693
63. Mandelstam S, Moon A. MRI of optic disc in childhood idiopathic intracranial hypertension. Pediatr Radiol. 2004;34:362
64. Kurz-Levin M, Landau K. A comparison of imaging techniques for diagnosing drusen of the optic nerve head. Arch Ophthalmol. 1999;117:1045-1049
65. Frisen L, Scholdstrom G, Svendsen P. Drusen in the optic nerve head: verification by computed tomography. Arch Ophthalmol. 1978;96:1611-1614
66. Boldt HC, Byrne SF, DiBernardo C. Echographic evaluation of optic disc drusen. J Clin Neuro-ophthalmol. 1991;11:85-91
67. Shuper A, Snir M, Barash D, Yassur Y, Minouni M. Ultrasonography of the optic nerves: clinical application in children with pseudotumor cerebri. J Pediatr. 1997;131:734-740
68. Trick GL, Bhatt SS, Dahl D, Skarf B. Optic disc topography in pseudopapilledema: a comparison to pseudotumor cerebri. J Neuro-Ophthalmol. 2001;21:240-244
69. Rowe FJ, Sarkies NJ. Assessment of visual function in idiopathic intracranial hypertension: a prospective study. Eye. 1998;12:111-118
70. Wall M, George D. Visual loss in pseudotumor cerebri: incidence and defects related to visual field strategy. Arch Neurol. 1987;44:170-175
71. Wall M, George D. Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain. 1991;114:155-180
72. Verplanck M, Kaufman DI, Parsons T, et al. Electrophysiology versus psychophysics in the detection of visual loss in pseudotumor cerebri. Neurology. 1988;38:1789-1792
73. Kaiser AM, Whitelaw AG. Normal cerebrospinal fluid pressure in the newborn. Neuropediatr. 1986;17:100-102
74. Welch K. Intracranial pressure in infants. J Neurosurg. 1980;52:693-699
75. Corbett JJ. Increased intracranial pressure: idiopathic and otherwise. J Neuro-Ophthalmol. 2004;24:103-105
76. Bono F, Lupo MR, Serra P, et al. Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology. 2002;59:1641-1643
77. Eide PK. Assessment of quality of continuous intracranial pressure recordings in children. Pediatr Neurosurg. 2006;42:28-34
78. Thuente DD, Buckley EG. Pediatric optic nerve sheath decompression. Ophthalmology. 2005;112:724-727
79. Shoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in case series. J Child Neurol. 1994;9:130-134
80. Weisberg LA, Chutorian AM. Pseudotumor cerebri of children. Am J Dis Child. 1977;131:1243-1248
81. Liu GT, Kay MD, Bienfang DC, Schatz NJ. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol. 1994;117:352-357
82. Lueck C, McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev. 2002;CD003434
83. Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997;49:734-739
84. Eggenberg ER, Miller NR, Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology. 1996;46:1524-1529
85. Curry WT, Butler WE, Barker FG. Rapidly rising incidence of cerebrospinal shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurg. 2005;57:87-108
86. Rekate HL, Wallace D. Lumboperitoneal shunts in children. Pediatr Neurosurg. 2003;38:41-46
87. Chumas PD, Kulkarni AV, Drake JM, Hoffman HJ, Humphreys RP, Rutka JT. Lumboperitoneal shunting: a retrospective study in a pediatric population. Neurosurg Online. 1993;32:376-383
88. Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000;107:1907-1912
89. Lee AG, Patrinely JR, Edmond JC. Optic nerve sheath decompression in pediatric pseudotumor cerebri. Ophthalm Surg Las. 1998;29:514-517
90. Patrocinio JA, Patricinio LG, Ruiz FB, Rodrigues da Cunha A. Endoscopic decompression of the optic nerve in pseudotumor cerebri. Auris Nasus Larynx. 2005;32:199-203
91. Carter S, Seiff SR. Macular changes in pseudotumor cerebri before and after optic nerve sheath fenestration. Ophthalmology. 1995;102:937-941
92. Keltner JL. Optic nerve sheath decompression. How does it work? Has its time come? Arch Ophthalmol. 1988;106:1365-1369
93. Mittra RA, Sergott RC, Flaharty PM, et al. Optic nerve decompression improves hemodynamic parameters in papilledema. Ophthalmology. 1993;100:987-997
94. Ngyun R, Carta A, Geleris A, et al. Long-term effect of optic nerve sheath decompression on intracranial pressure in pseudotumor cerebri. Invest Ophth Vis Sci. 1997;8:S388
95. Tsai JC, Petrovich MS, Sadun AA. Histopathological and ultrastructural examination of optic nerve sheath decompression. Br J Ophthalmol. 1995;79:1825
96. Kessler LA, Novelli PM, Reigel DH. Surgical treatment of benign intracranial hypertension-subtemporal decompression revisited. Surg Neurol. 1998;50:73-76
97. Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology. 1993;100:686-690
98. Brolin RE. Bariatric surgery and long-term control of obesity. JAMA. 2002;288:2793-2796
99. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737
100. Sugerman HJ, Sugerman EL, DeMaria EJ, Kellum JM, Kennedy C, Mowery Y. Bariatric surgery for severely obese adolescents. J Gastrointest Surg. 2003;7:102-107
101. Lessel S, Rosman NP. Permanent visual impairment in childhood pseudotumor cerebri. Arch Neurol. 1986;43:801-804
102. Rowe FJ, Sarkies NJ. Visual outcome in a prospective study of idiopathic intracranial hypertension. Arch Ophthalmol. 1999;117:1571
103. Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension risk of recurrences. Neurology. 2004;63:1737-1739